Fondaparinux has the edge over enoxaparin in ACS

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1505, 2005-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fondaparinux better than enoxaparin or UFH in ACS

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Fondaparinux cost saving over enoxaparin for VTE prophylaxis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 457, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Ezetimibe has the edge over statin monotherapy

Inpharma, Vol. 1, Iss. 1431, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Fondaparinux versus enoxaparin for the prevention of venous thromboembolism

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 455-457

Informa Healthcare

Access to resources Recommend Favorite

Enoxaparin sodium superior to heparin for ACS therapy

Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite